Nanoemulsions: Colloidal topical delivery systems for antiacne agents- A Mini-Review

Nanomedicine Research Journal

Volumn 2, Issue 1, 2017, Pages 49-56

  Najafi Taher, Roqya ^a   Amani, Amir ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acne; Nanoemulsion; Topical treatment

Indexed keywords

EID: 85016502030     PISSN: 24763489     EISSN: 24767123     Source Type: Journal    
DOI: 10.22034/NMRJ.2017.23532     Document Type: Review

References (66)

1. Nguyen CM, Koo J, Cordoro KM. Psychodermatologic Effects of Atopic Dermatitis and Acne: A Review on Self‐Esteem and Identity. Pediatr Dermatol. 2016;33(2):129-35.
2. Shalita AR. Acne: clinical presentations. Clin Dermatol. 2004;22(5):385-6.
3. Jacob CI, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol. 2001;45(1):109-17.
4. Canavan TN, Chen E, Elewski BE. Optimizing Non-Antibiotic Treatments for Patients with Acne: A Review. Dermatol Ther. 2016:1-24.
5. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. The Lancet. 2012;379(9813):361-72.
6. Garg T. Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. 2016;44(1):98-105.
7. Thielitz A, Abdel‐Naser MB, Fluhr JW, Zouboulis CC, Gollnick H. Topical retinoids in acne–an evidence‐based overview. JDDG: J Dtsch Dermatol. 2008;6(12):1023-31.
8. Gallo RL, Nakatsuji T. Microbial symbiosis with the innate immune defense system of the skin. J. Invest. Dermatol. 2011;131(10):1974-80.
9. Lazic Mosler E, Leitner C, Gouda MA, Carter B, Layton AM, KhalafAllah MT. Topical antibiotics for acne. The Cochrane Library. 2016.
10. Lalla J, Nandedkar S, Paranjape M, Talreja N. Clinical trials of ayurvedic formulations in the treatment of acne vulgaris. J Ethnopharmacol. 2001;78(1):99-102.
11. Griffiths G, Trueman L, Crowther T, Thomas B, Smith B. Onions—a global benefit to health. Phytother Res. 2002;16(7):603-15.
12. Malhi HK, Tu J, Riley TV, Kumarasinghe SP, Hammer KA. Tea tree oil gel for mild to moderate acne; a 12 week uncontrolled, open-label phase II pilot study. Australas J Dermatol. 2016:1-6
13. Garshick MK, Kimball A, Drake L. Systemic Therapies for Acne. Acne Erup Dermatol. 2014:27-34.
14. Simonart T. Newer approaches to the treatment of acne vulgaris. Am J Clin Dermatol. 2012;13(6):357-64.
15. Ricci F, Masini F, Fossati B, Frascione P, De Waure C, Capizzi R, et al. Combination therapy with hydrogen peroxide (4%), salicylic acid (0.5%) and D-panthenol (4%): efficacy and skyn tolerability in common acne vulgaris during sun exposure period. Eur Rev Med Pharmacol Sci. 2016;20(2):232-6.
16. Akarsu S, Fetil E, YÜCEL F, GÜL E, GÜNEŞ AT. Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris. J Dermatol. 2012;39(5):433-8.
17. Seidler EM, Kimball AB. Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/ clindamycin in acne. J Am Acad Dermatol. 2010;63(1):52-62.
18. Yentzer BA, McClain RW, Feldman SR. Do topical retinoids cause acne to" flare"? . J Drugs Dermatol. 2009;8(9):799-801.
19. Rademaker M. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin. Australas J Dermatol. 2010;51(4):248-53.
20. Gollnick HP, Krautheim A. Topical treatment in acne: current status and future aspects. Dermatol. 2003;206(1):29-36.
21. Aytekin M, Gursoy RN, Ide S, Soylu EH, Hekimoglu S. Formulation and characterization of liquid crystal systems containing azelaic acid for topical delivery. Drug Dev Ind Pharm. 2013;39(2):228-39.
22. Shah KA, Date AA, Joshi MD, Patravale VB. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int. J. Pharm. 2007;345(1):163-71.
23. Mandawgade SD, Patravale VB. Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int. J. Pharm.. 2008;363(1):132-8.
24. Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. Isotretinoinloaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm. 2007;328(2):191-5.
25. Münster U, NakamuraNachname C, Haberland A, Jores K, Mehnert W, Rummel S, et al. RU 58841-myristate–prodrug development for topical treatment of acne and androgenetic alopecia. Die Pharmazie-Int. J Pharm Sci. 2005;60(1):8-12.
26. Štecová J, Mehnert W, Blaschke T, Kleuser B, Sivaramakrishnan R, Zouboulis CC, et al. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm Res. 2007;24(5):991-1000.
27. Layegh P, Mosallaei N, Bagheri D, Jaafari MR, Golmohammadzadeh S. The efficacy of isotretinoin-loaded solid lipid nanoparticles in comparison to Isotrex® on acne treatment. Nanomed J. 2013;1(1):38-47.
28. Domínguez-Delgado CL, Rodríguez-Cruz IM, Escobar-Chávez JJ, Calderón-Lojero IO, Quintanar-Guerrero D, Ganem A. Preparation and characterization of triclosan nanoparticles intended to be used for the treatment of acne. Eur. J. Pharm. Biopharm. 2011;79(1):102-7.
29. Biju S, Ahuja A, Khar RK. Tea tree oil concentration in follicular casts after topical delivery: Determination by high-performance thin layer chromatography using a perfused bovine udder model. J. Pharm. Sci. 2005;94(2):240-5.
30. Maali A, Mosavian MH. Preparation and application of nanoemulsions in the last decade (2000–2010). J DISPER SCI TECHNOL. 2013;34(1):92-105.
31. Lovelyn C, Attama AA. Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol . 2011;2(05):626-639
32. McClements DJ, Rao J. Food-grade nanoemulsions: formulation, fabrication, properties, performance, biological fate, and potential toxicity. Crit Rev Food Sci Nutr. 2011;51(4):285-330.
33. Qian C, McClements DJ. Formation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: factors affecting particle size. Food Hydrocoll. 2011;25(5):1000-8.
34. Esmaeili F, Rajabnejhad S, Partoazar AR, Mehr SE, Faridi-Majidi R, Sahebgharani M, et al. Anti-inflammatory effects of eugenol nanoemulsion as a topical delivery system. Pharm. Dev. Technol. 2015:1-7.
35. Khani S, Keyhanfar F, Amani A. Design and evaluation of oral nanoemulsion drug delivery system of mebudipine. Drug Delive. 2016;23(6):2035-43.
36. Amani A, York P, Chrystyn H, Clark BJ, Do DQ. Determination of factors controlling the particle size in nanoemulsions using Artificial Neural Networks. Eur. J. Pharm. Sci. 2008;35(1):42-51.
37. Amani A, York P, Chrystyn H, Clark BJ. Factors affecting the stability of nanoemulsions—use of artificial neural networks. Pharm Res. 2010;27(1):37-45.
38. Amani A, York P, Chrystyn H, Clark BJ. Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers. Aaps Pharmscitech. 2010;11(3):1147-51.
39. Alam MS, Sharma P. FORMULATION AND EVALUATION OF CLOBETASOL PROPIONATE LOADED NANOEMULSION GEL CONTAINING TEA TREE OIL. WJPPS. 2016:616-628
40. Sharma S, Sarangdevot K. Nanoemulsions for cosmetics. IJARPB. 2012;1(3):408-15.
41. Sonneville-Aubrun O, Simonnet J-T, L'alloret F. Nanoemulsions: a new vehicle for skincare products. Adv. Colloid Interface Sci. 2004;108:145-9.
42. Jean-Thierry Simonnet OS, Sylvie Legret NANOEMULSION BASED ON OXYETHYLENATED OR NON-OXYETHYLENATED SORBITAN FATTY ESTERS AND ITS USES IN THE COSMETICS, DERMATOLOGICAL AND/OR OPHTALMOLOGICAL FIELDS US 6,335,022 B1.
43. Jean-Thierry Simonnet OS, Sylvie Legret. NANOEMULSION BASED ON ETHYLENEOXIDE AND PROPYLENE OXIDE BLOCK COPOLYMER AND ITS USES IN THE COSMETICS, DERMATOLOGICAL AND/OR OPHTALMOLOGICAL FIELDS 2002;US 6,464,990 B2.
44. Jean-ThierrySimonnet OS, Sylvie Legret. NANOEMULSION BASED ON SUGAR FATTY ESTERS AND ON SUGAR FATTY ETHERS AND ITS USES IN THE COSMETICS, DERMATOLOGICAL AND/OR OPHTALMOLOGICAL FIELDS 2004;US 6,689,371 B1.
45. Alain Ribier J-TS, Sylvie Legret. TRANSPARENT NANOEMULSION LESS THAN 100 NM BASED ON FLUID NON-IONIC AMPHIPHILIC LIPIDS AND USE IN COSMETIC OR IN DERMOPHARMACEUTICALS. 1998;US 5,753,241.
46. Denet A-R, Vanbever R, Préat V. Skin electroporation for transdermal and topical delivery. Adv. Drug Deliv. Rev. 2004;56(5):659-74.
47. Hoeller S, Sperger A, Valenta C. Lecithin based nanoemulsions: A comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical behaviour and skin permeation. Int. J. Pharm. 2009;370(1):181-6.
48. POTTS RO, MAK VH, GUY RH. Strategies to enhance permeability via stratum corneum lipid pathways. Advances in Lipid Research: Skin Lipids. 2016(24):173-210
49. Som I, Bhatia K, Yasir M. Status of surfactants as penetration enhancers in transdermal drug delivery. J Pharm Bioall Sci. 2012;4(1):2-9
50. Ghanem A-H, Mahmoud H, Rohr UD, Borsadia S, Liu P, Fox JL, et al. The effects of ethanol on the transport of β-estradiol and other permeants in hairless mouse skin. II. J. Control. Release. 1987;6(1):75-83.
51. Lane ME. Skin penetration enhancers. Int. J. Pharm. 2013;447(1):12-21.
52. Gupta RR, Jain SK, Varshney M. AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surf., B. 2005;41(1):25-32.
53. Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 1). Trop J Pharm Res. 2013;12(2):255-64.
54. Sunilendu Bhaushan Roy JSK, Shafigh Sheikh, Suresh Pancholi, Dasharathalal Patel, Ravidra Mittal. PHARMACEUTICAL OF ANTI ACNE AGENTS. 2013;US 2013/0280308 A1.
55. de Almeida Borges VR, Simon A, Sena ARC, Cabral LM, de Sousa VP. Nanoemulsion containing dapsone for topical administration: a study of in vitro release and epidermal permeation. Int J Nanomedicine. 2013;8:535.
56. Faiyazuddin M, Baboota S, Ali J, Ahuja A, Ahmad S. Characterization and in vitro bioactive studies of lemongrass oil phytonanoemulsion system in the treatment of acne vulgaris. IJEOT. 2009;3(1):13-21.
57. Kumar A, Agarwal S, Ahuja A, Ali J, Choudhry R, Baboot S. Preparation, characterization, and in vitro antimicrobial assessment of nanocarrier based formulation of nadifloxacin for acne treatment. Die Pharmazie-Int. J Pharm Sci. 2011;66(2):111-4.
58. Jiyauddin K, Fadli A, Wei J, Jawad A, Samer A, Kaleemullah M, et al. FORMULATION OF CLINDAMYCIN NANOEMULSION. IJPSR. 2015;6(5): 1845-1854
59. Miastkowska M, Sikora E, Ogonowski J, Zielina M, Łudzik A. The kinetic study of isotretinoin release from nanoemulsion. Colloids Surf., A. 2016;510:63-8.
60. Prasad S, Mukhopadhyay A, Kubavat A, Kelkar A, Modi A, Swarnkar B, et al. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial. Indian J. Dermatol. Venereol. Leprol.. 2012;78(4):459.
61. Wooster TJ, Golding M, Sanguansri P. Impact of oil type on nanoemulsion formation and Ostwald ripening stability. Langmuir. 2008;24(22):12758-65.
62. Chaudhary M, Naithani V. Topical herbal formulation for treatment of acne and skin disorders; 2012: EP2370057 A1.
63. Stevensen CJ. Aromatherapy in dermatology. Clin Dermatol. 1998;16(6):689-94.
64. Mandal A, Bera A. Surfactant stabilized nanoemulsion: characterization and application in enhanced oil recovery. WASET. 2012;6(7):537-42.
65. Bouchemal K, Briançon S, Perrier E, Fessi H. Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation. Int. J. Pharm. 2004;280(1):241-51.
66. Priya S, Koland M, Kumari S. NANOEMULSION COMPONENTS SCREENING OF QUETIAPINE FUMARATE: EFFECT OF SURFACTANT AND CO SURFACTANT. Asian J Pharm Clin Res. 2015;8(6):136-40.